Anthem Biosciences shares surged 3.3% to Rs 746.70 during Monday’s intraday trading session on BSE, after making a strong debut with a 27% premium over its IPO price.The company’s IPO investors are now sitting on overall gains of around 31%.

Disclaimer

Hello and thank you for visiting GoldSilverReports.com.

Please note that all the information shared on this website is for informational and educational purposes only. We try our best to provide accurate, up-to-date, and useful content, but we cannot guarantee that everything is 100% correct or complete at all times.

We are not financial advisors, and nothing on this site should be taken as financial, investment, or trading advice. Before making any financial decisions, please do your own research or talk to a qualified expert.

GoldSilverReports.com will not be held responsible for any loss or damage that may happen by using the information found on this website. You are fully responsible for how you use the content here.

Also, we may sometimes share links to other websites. We do this for your convenience, but we are not responsible for what those websites say or do.

By using our website, you agree to this disclaimer.

Thank you for your understanding and support!